Elena Barbieri

Modena, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Emotional distress, guilt and impact on reproductive decision-making in women with BRCA1/2 mutations.

Emotional distress, guilt and impact on reproductive decision-making in women with BRCA1/2 mutations.

Journal: Breast (Edinburgh, Scotland)

Published: March 05, 2026

Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019.

Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study.

Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study.

Journal: Familial cancer

Published: December 15, 2025

Association between risk-reducing salpingooophorectomy and bone health in women with hereditary breast and ovarian cancer syndrome.

Association between risk-reducing salpingooophorectomy and bone health in women with hereditary breast and ovarian cancer syndrome.

Journal: Menopause (New York, N.Y.)

Published: November 18, 2025

Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer.

Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer.

Journal: NPJ breast cancer

Published: August 28, 2025

Characterization of Copy Number Variants in Hereditary Cancer Patients Through NGS Shows a Distinctive PALB2 Contribution to the Diagnostic Yield.

Characterization of Copy Number Variants in Hereditary Cancer Patients Through NGS Shows a Distinctive PALB2 Contribution to the Diagnostic Yield.

Journal: Human mutation

Published: May 13, 2025

Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat study.

Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat study.

Journal: NPJ breast cancer

Published: February 09, 2025

Chemoprevention strategies in hereditary breast and ovarian cancer syndromes.

Chemoprevention strategies in hereditary breast and ovarian cancer syndromes.

Journal: Tumori

Published: November 21, 2024

Evaluation of an Italian Population-Based Programme for Risk Assessment and Genetic Counselling and Testing for BRCA1/2-Related Hereditary Breast and Ovarian Cancer after 10 Years of Operation: An Observational Study Protocol.

Evaluation of an Italian Population-Based Programme for Risk Assessment and Genetic Counselling and Testing for BRCA1/2-Related Hereditary Breast and Ovarian Cancer after 10 Years of Operation: An Observational Study Protocol.

Journal: Methods and protocols

Published: June 25, 2024

Can contralateral prophylactic mastectomy and oophorectomy increase survival in BRCA-related breast cancer? Results from the Italian MUTina study.

Can contralateral prophylactic mastectomy and oophorectomy increase survival in BRCA-related breast cancer? Results from the Italian MUTina study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: May 31, 2024

Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients.

Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 14, 2024

Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndrome.

Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndrome.

Journal: Communications medicine

Published: March 14, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026